Oncology Detection
Minimal Residual Disease (MRD) / Early Detection
Research/Pre-clinicalActive
Key Facts
Indication
Minimal Residual Disease (MRD) / Early Detection
Phase
Research/Pre-clinical
Status
Active
Company
About Atila Biosystems
Atila Biosystems is a private, pre-revenue diagnostics company founded in 2018 and based in Mountain View, California. The company's core innovation is its iAMP technology, a proprietary isothermal amplification method designed for high sensitivity, multiplexing, and ease of use in decentralized settings. Its initial pipeline targets high-impact areas including sexually transmitted infections (STIs), respiratory viruses, and oncology, with the goal of providing faster, more accessible, and more comprehensive diagnostic results than current PCR or lateral flow methods. The company is positioned to compete in the rapidly growing point-of-care and decentralized diagnostics market.
View full company profile